Cargando…
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury
Vascular endothelial growth factor pathway inhibitors (VEGFi), used as anti-angiogenic drugs to treat cancer are associated with cardiovascular toxicities through unknown molecular mechanisms. Endothelial cell-derived microparticles (ECMPs) are biomarkers of endothelial injury and are also functiona...
Autores principales: | Neves, Karla B, Rios, Francisco J, Jones, Robert, Evans, Thomas Ronald Jeffry, Montezano, Augusto C, Touyz, Rhian M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452312/ https://www.ncbi.nlm.nih.gov/pubmed/30753341 http://dx.doi.org/10.1093/cvr/cvz021 |
Ejemplares similares
-
Microparticles Induce Cell Cycle Arrest Through Redox-Sensitive Processes in Endothelial Cells: Implications in Vascular Senescence
por: Burger, Dylan, et al.
Publicado: (2012) -
Endothelial Microparticle-Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function
por: Burger, Dylan, et al.
Publicado: (2016) -
Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
por: Neves, Karla B., et al.
Publicado: (2023) -
Cardiotoxicity with vascular endothelial growth factor inhibitor therapy
por: Touyz, Rhian M., et al.
Publicado: (2018) -
Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells
por: Alves-Lopes, Rheure, et al.
Publicado: (2023)